Back to Agenda
Live Oral Poster Presentations I
Session Chair(s)
Vedran Raguz
Scientific Programs Specialist, DIA, Switzerland
This session is an opportunity to hear Authors present their Posters Live, followed by a Q&A portion.
Learning Objective : The European Commission’s (EC) Pharmaceutical Strategy for Europe aimed to develop a future-proof pharmaceutical policy. This study aims to assess stakeholders' views on patient-centric policy initiatives and the prospects for patient-experience data (PED), expressed in the Pharmaceutical Strategy.
Speaker(s)
Io Wens, MSC
PhD Researcher, KU Leuven University, Belgium
Towards patient-centered pharmaceutical policy-making: Stakeholders’ perspectives on the Pharmaceutical Strategy for Europe
Anna Litsiou, PHD, MBA, MSC
Regulatory Policy & Intelligence Director, AstraZeneca, United Kingdom
Sustainable Regulatory Framework: A toolkit of regulatory processes and tools to enable patient access and foster innovation
Alice Vanneste, MSC
PhD Student, KU Leuven, Belgium
Advancing Patient Experience Data in Healthcare Decision-Making: Multi-stakeholders’ insights on policy ways forward
Marjon Pasmooij, PHD
Head Science Department, MEB, Netherlands
Data science and artificial intelligence to study the drug regulatory system: current and future avenues
Antoine Manson, PHARMD, MPHARM, MS
Senior Manager, Regulatory Policy and Science, Bayer, United States
Using AI to Accelerate Medicines Development: An Evolving EU Regulatory Landscape
Katelyn Rivas, PHD
Regulatory Medical Writer, Synterex, Inc., United States
Lessons Learned: A Supplier’s Perspective on Strategies for Promoting Sustainability in the Regulatory Submissions Process
Dan Reed, PHD
Senior Regulatory Intelligence Director, AstraZeneca, United Kingdom
Regulatory science considerations for cell and gene therapy in chronic diseases: cardiovascular disease as a case study
Carolyn Hynes, PHD
Senior Director Regulatory Intelligence, AstraZeneca, United Kingdom
Access to Medicines: Models for future Regulatory Authority and HTA body work-sharing?
Sevengul Car, MS, MSC
PhD researcher, KU Leuven, Belgium
Evolving Global Regulatory Landscape for Approval of Biosimilars: Current Challenges and Future Considerations
Have an account?